Belgium
CluePoints is an Information Technology startup based in Belgium, founded in 2012. The company's slogan, "AI-Powered Risk-Based Quality Management (RBQM) & Data Quality Oversight Solutions," encapsulates its core focus on leveraging AI, advanced statistics, and ML to ensure the quality, accuracy, and integrity of clinical trial data. Aligned with regulatory guidance from the FDA, EMA, ICH, and MHRA, CluePoints supports central and on-site monitoring, medical review, and quality risk management, driving a holistic risk-based strategy.
CluePoints aims to drive positive clinical development outcomes, increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBQM. The company's approach includes thought leadership, consulting expertise for risk assessment, and solution implementation.
The most recent investment in CluePoints was a Private Equity Round at 01 September 2020, led by Summit Partners. This investment reflects the confidence of private equity investors in CluePoints' AI-powered solutions for improved clinical trial quality management and data oversight.
Through its innovative approach and strategic partnerships, CluePoints is poised to continue making significant strides in the realm of AI-powered RBQM and data quality oversight solutions, addressing critical needs within the clinical trial landscape.
